skip to Main Content
 

Benchmark Survey Results

  • This page as PDF

Summary

A June 2014 Avalere survey asserts that while 90% of pharmaceutical and biotech manufacturers are offering cost-sharing assistance to exchange patients, the type of support, generosity and program structure vary widely.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

Panelists

Sign up to receive more insights about
Please enter your email address to be notified when new insights are published.

Back To Top